GB0101312D0 - Assay - Google Patents

Assay

Info

Publication number
GB0101312D0
GB0101312D0 GBGB0101312.7A GB0101312A GB0101312D0 GB 0101312 D0 GB0101312 D0 GB 0101312D0 GB 0101312 A GB0101312 A GB 0101312A GB 0101312 D0 GB0101312 D0 GB 0101312D0
Authority
GB
United Kingdom
Prior art keywords
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0101312.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0101312.7A priority Critical patent/GB0101312D0/en
Publication of GB0101312D0 publication Critical patent/GB0101312D0/en
Priority to JP2002558535A priority patent/JP2004520041A/ja
Priority to US10/466,258 priority patent/US7270962B2/en
Priority to EP02715526A priority patent/EP1390758A2/en
Priority to PCT/GB2002/000228 priority patent/WO2002057483A2/en
Priority to AU2002225174A priority patent/AU2002225174A1/en
Priority to US11/836,887 priority patent/US20070286851A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
GBGB0101312.7A 2001-01-18 2001-01-18 Assay Ceased GB0101312D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0101312.7A GB0101312D0 (en) 2001-01-18 2001-01-18 Assay
JP2002558535A JP2004520041A (ja) 2001-01-18 2002-01-18 新規アッセイ
US10/466,258 US7270962B2 (en) 2001-01-18 2002-01-18 Method of identifying modulators of nogo-functions
EP02715526A EP1390758A2 (en) 2001-01-18 2002-01-18 Method of identifying modulators of nogo-functions
PCT/GB2002/000228 WO2002057483A2 (en) 2001-01-18 2002-01-18 Method of identifying modulators of nogo-functions
AU2002225174A AU2002225174A1 (en) 2001-01-18 2002-01-18 Method of identifying modulators of nogo-functions
US11/836,887 US20070286851A1 (en) 2001-01-18 2007-08-10 Method of Identifying Modulators of NOGO-Functions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101312.7A GB0101312D0 (en) 2001-01-18 2001-01-18 Assay

Publications (1)

Publication Number Publication Date
GB0101312D0 true GB0101312D0 (en) 2001-02-28

Family

ID=9907052

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0101312.7A Ceased GB0101312D0 (en) 2001-01-18 2001-01-18 Assay

Country Status (6)

Country Link
US (2) US7270962B2 (https=)
EP (1) EP1390758A2 (https=)
JP (1) JP2004520041A (https=)
AU (1) AU2002225174A1 (https=)
GB (1) GB0101312D0 (https=)
WO (1) WO2002057483A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011130347A2 (en) * 2010-04-13 2011-10-20 The Johns Hopkins University Methods for enhancing axonal regeneration
CN119768424A (zh) * 2022-08-22 2025-04-04 舒泰神（北京）生物制药股份有限公司 特异性识别Nogo-A的抗体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ304224B6 (cs) * 1998-11-06 2014-01-15 Schwab Monoklonální protilátka
US7087399B1 (en) * 1999-05-13 2006-08-08 Scios, Inc. β-secretase and modulation of β-secretase activity
IL150566A0 (en) 2000-01-12 2003-02-12 Univ Yale Nucleic acids and polypeptides and nogo-receptor proteins
GB0101313D0 (en) 2001-01-18 2001-02-28 Glaxo Group Ltd Assay

Also Published As

Publication number Publication date
US7270962B2 (en) 2007-09-18
JP2004520041A (ja) 2004-07-08
US20070286851A1 (en) 2007-12-13
US20040132096A1 (en) 2004-07-08
WO2002057483A2 (en) 2002-07-25
WO2002057483A3 (en) 2003-04-24
EP1390758A2 (en) 2004-02-25
AU2002225174A1 (en) 2002-07-30

Similar Documents

Publication Publication Date Title
HUP0303809A3 (en) Assay system
EP1470421A4 (en) BIOLOGICAL ASSAY FOR RAPIDLY DETECTING THE PRESENCE OF PRIONS
GB0120126D0 (en) Assay device
EP1442299A4 (en) TRIAL
GB0012860D0 (en) Assay
GB0115777D0 (en) Assay
PL370539A1 (en) Assay
GB0008784D0 (en) Assay
GB0120589D0 (en) Assay
GB0101313D0 (en) Assay
GB0121440D0 (en) Assay
GB0003902D0 (en) Assay
GB0005894D0 (en) Assay
GB0127132D0 (en) Assay
GB0010960D0 (en) Assay
GB0100782D0 (en) Assay
GB0101312D0 (en) Assay
GB0025804D0 (en) Assay
GB0001703D0 (en) Assay
GB0105362D0 (en) Assay
GB0100290D0 (en) Assay
GB0013561D0 (en) Assay
GB0019242D0 (en) Assay
GB0003898D0 (en) Assay
GB0023239D0 (en) Assay

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)